---

Referenser

1. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Federico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA : the journal of the American Medical Association. 2001;285(16):2114-20.

2. Hanséus K, Jägervall M, Norman M. Barnmedicin. Femte upplagan ed2020. 914 sidor p.

3. ePed. Evidence- and Experience based Pediatric Drug Information  [Available from: http://www.eped.se.

4. Läkemedelsverket. Säkrare ordination och läkemedelshantering till barn 2017 [Available from: https://lakemedelsverket.se/Alla-nyheter/NYHETER-2017/Sakrare-ordination-och-lakemedelshantering-till-barn/.

5. Lagercrantz H, Hellstrom-Westas L, Norman M. Neonatologi: Studentlitteratur; 2015.

6. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology--drug disposition, action, and therapy in infants and children. The New England journal of medicine. 2003;349(12):1157-67.

7. Neal-Kluever A, Fisher J, Grylack L, Kakiuchi-Kiyota S, Halpern W. Physiology of the Neonatal Gastrointestinal System Relevant to the Disposition of Orally Administered Medications. Drug Metab Dispos. 2019;47(3):296-313.

8. DeLand FH, North WA. Relationship between liver size and body size. Radiology. 1968;91(6):1195-8.

9. Star K, Choonara I. Studying the Evolving Knowledge of Adverse Drug Reactions in Order to Facilitate the Rational Use of Medicines in Paediatric Patients. Healthcare (Basel). 2019;7(2).

10. Kimland E, Nydert P, Odlind V, Bottiger Y, Lindemalm S. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study. Acta Paediatr. 2012;101(7):772-8.

11. Penkov D, Tomasi P, Eichler I, Murphy D, Yao LP, Temeck J. Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United States. Ther Innov Regul Sci. 2017;51(3):360-71.

12. Alghamdi AA, Keers RN, Sutherland A, Ashcroft DM. Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review. Drug Saf. 2019;42(12):1423-36.

13. Mahmood I. Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. Clinical pharmacokinetics. 2014;53(4):327-46.

14. Helathcare Safety Investigation Branch (HSIB). Weight-based medication errors in children 2022 [Available from: https://www.hsib.org.uk/investigations-and-reports/weight-based-medication-errors-in-children/weight-based-medication-errors-in-children/.

15. Gubbins PO, Bertch KE. Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications. Clinical pharmacokinetics. 1991;21(6):431-47.

16. Al-Khouja A, Park K, Anderson DJC, Young C, Wang J, Huang SM, et al. Dosing Recommendations for Pediatric Patients With Renal Impairment. Journal of clinical pharmacology. 2020;60(12):1551-60.

17. Rees L, Bockenhauer D, Webb N, Punaro M. Paediatric Nephrology: Oxford Specialist Handbooks in Paediatrics; 2019.

18. Andersson AC, Nydert P, Paulsson M. Preparing paediatric medicines by dissolving tablets and extracting a portion may compromise dosing accuracy. Acta Paediatr. 2023;112(12):2560-2.

19. Conn RL, Kearney O, Tully MP, Shields MD, Dornan T. What causes prescribing errors in children? Scoping review. BMJ open. 2019;9(8):e028680.

20. Smyth RL, Peak M, Turner MA, Nunn AJ, Williamson PR, Young B, et al.  ADRIC: Adverse Drug Reactions In Children - a programme of research using mixed methods. Programme Grants for Applied Research. Southampton (UK)2014.

21. Bracken L, McDonough E, Ashleigh S, Wilson F, Shakeshaft J, Ohia U, et al. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)). BMJ open. 2020;10(10):e036508.

22. El Edelbi R, Eksborg S, Lindemalm S. In situ coating makes it easier for children to swallow and tolerate tablets and capsules. Acta Paediatr. 2015;104(9):956-61.

23. Bergene EH, Ro TB, Steinsbekk A. Strategies parents use to give children oral medicine: a qualitative study of online discussion forums. Scand J Prim Health Care. 2017;35(2):221-8.

24. Janusinfo. Inhalera rätt  [Available from: https://janusinfo.se/fortbildning/fortbildningfilmer/filmer/inhaleraratt.5.20326f62163f95008f17fe76.html.

25. Marzuillo P, Guarino S, Barbi E. Paracetamol: a focus for the general pediatrician. European journal of pediatrics. 2014;173(4):415-25.

26. Giftinformationscentralen. Förgiftningar hos barn  [Available from: https://giftinformation.se/Las-mer/forgiftningar-barn/.

27. Falagas ME, Vouloumanou EK, Plessa E, Peppas G, Rafailidis PI. Inaccuracies in dosing drugs with teaspoons and tablespoons. Int J Clin Pract. 2010;64(9):1185-9.

28. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. The Cochrane database of systematic reviews. 2014(11):CD001831.

29. Skolverket. Egenvård i förskola, skola och fritidshem  [Available from: https://www.skolverket.se/regler-och-ansvar/ansvar-i-skolfragor/egenvard-i-forskola-skola-och-fritidshem.

30. Läkemedelsverket. Behandling av sömnstörningar hos barn och ungdomar – behandlingsrekommendation  [Available from: https://www.lakemedelsverket.se/sv/behandling-och-forskrivning/behandlingsrekommendationer/sok-behandlingsrekommendationer/behandling-av-somnstorningar-hos-barn-och-ungdomar--kunskapsdokument.

31. Aston J, Wilson KA, Terry DRP. The treatment-related experiences of parents, children and young people with regular prescribed medication. Int J Clin Pharm. 2019;41(1):113-21.

32. Leeder JS, Gaedigk A, Wright KJ, Staggs VS, Soden SE, Lin YS, et al. A longitudinal study of cytochrome P450 2D6 (CYP2D6) activity during adolescence. Clin Transl Sci. 2022;15(10):2514-27.